 ecancermedicalscience | Intensive chemotherapy dramatically improves recurrence and survival in ... ecancermedicalscience Younger patients with diffuse large B-cell lymphoma given a more intensive regimen of chemotherapy combined with rituximab survive significantly longer, and are approximately twice as likely to remain in remission 3 years later, compared with patients ... Intensified Immunochemotherapy Benefits B-Cell Lymphoma Intense Chemo Best for Aggressive Lymphoma |
